The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood Pressure: The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study
Abstract
Transforming growth factor-β1 (TGF-β1) plays an important role in the modulation of cellular growth and differentiation and the production and degradation of the extracellular matrix. A number of experimental results suggest that TGF-β1 may be involved in cardiovascular physiopathology. In the present study, we assessed whether the TGF-β1 gene is a candidate gene for coronary heart disease or hypertension. We screened the coding region and 2181 bp upstream of the TGF-β gene for polymorphisms and identified seven polymorphisms: 3 in the upstream region of the gene at positions −988, −800, and −509 from the first transcribed nucleotide; 1 in a nontranslated region at position +72; 2 in the signal peptide sequence Leu 10 →Pro, Arg 25 →Pro; and 1 in the region of the gene coding for the precursor part of the protein not present in the active form, Thr 263 →Ile. We analyzed these TGF-β1 polymorphisms in 563 patients with myocardial infarction and 629 control subjects from four regions in Northern Ireland and France. The Pro 25 allele was more frequent in patients than in control subjects in Belfast ( P <.01) and Strasbourg ( P <.05). The TGF-β1 polymorphisms were not associated with the degree of angiographically assessed coronary artery disease in patients. The presence of a Pro 25 allele was associated with a lower systolic pressure in the four control groups ( P <.002), and a history of hypertension was significantly less frequent in homozygotes or heterozygotes for Pro 25 than in homozygotes for Arg 25 (odds ratio, 0.43; 95% confidence interval, 0.19 to 0.92; P <.03). Since the Pro 25 allele was associated with an increased risk of myocardial infarction and a reduced risk of hypertension, we favor a cautious interpretation of these apparently inconsistent results. Other studies will need to verify whether these associations are real.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Molecular Evolutionary Genetics
Nei, M. (1987) · Columbia University Press eBooks · doi:10.7312/nei-92038 · Cited by 15,271
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Saiki, R. K., Bugawan, T. L., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1986) · Nature · doi:10.1038/324163a0 · Cited by 1,827
Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B., & Goeddel, D. V. (1985) · Nature · doi:10.1038/316701a0 · Cited by 1,667
Zeiher, A. M., Drexler, H., Wollschläger, H., & Just, H. (1991) · Circulation · doi:10.1161/01.cir.83.2.391 · Cited by 995
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Lyons, R. M., Gentry, L. E., Purchio, A. F., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1361 · Cited by 737
GENETIC ANALYSIS OF PROTEIN EXPORT IN ESCHERICHIA COLI K12
Benson, S. A., Hall, M. N., & Silhavy, T. J. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.000533 · Cited by 428
Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein(a)
Grainger, D. J., Kirschenlohr, H. L., Metcalfe, J. C., Weissberg, P. L., Wade, D. P., & Lawn, R. M. (1993) · Science · doi:10.1126/science.8503012 · Cited by 408
Characterization of the Promoter Region of the Human Transforming Growth Factor-β1 Gene
Kim, S. J., Glick, A., Sporn, M. B., & Roberts, A. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31272-3 · Cited by 393
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Ohno, M., Cooke, J. P., Dzau, V. J., & Gibbons, G. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117787 · Cited by 359
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M., & Metcalfe, J. C. (1994) · Nature · doi:10.1038/370460a0 · Cited by 352
Mediation of Cardioprotection by Transforming Growth Factor-β
Lefer, A. M., Tsao, P., Aoki, N., & Palladino, M. A. (1990) · Science · doi:10.1126/science.2164258 · Cited by 299
Ye, S., Green, F. R., Scarabin, P. Y., Nicaud, V, Bara, L., Dawson, S. J., Humphries, S. E., Evans, A., Luc, G., Cambou, J. P., et al. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649833 · Cited by 234
Self-citationParra, H. J., Arveiler, D., Evans, A. E., Cambou, J. P., Amouyel, P., Bingham, A., McMaster, D., Schaffer, P., Douste-Blazy, P., & Luc, G. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.701 · Cited by 233
Self-citationKojima, S., Harpel, P. C., & Rifkin, D. B. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.6.1439 · Cited by 229
Endothelial Adhesiveness for Blood Neutrophils Is Inhibited by Transforming Growth Factor-β
Gamble, J. R., & Vadas, M. A. (1988) · Science · doi:10.1126/science.3175638 · Cited by 221
Unity in Function in the Absence of Consensus in Sequence: Role of Leader Peptides in Export
Randall, L. L., & Hardy, S. J. S. (1989) · Science · doi:10.1126/science.2646712 · Cited by 221
Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells
Gamble, J. R., Khew-Goodall, Y., & Vadas, M. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4494 · Cited by 210
Takahashi, N., Calderone, A., Izzo, N. J., Mäki, T. M., Marsh, J. D., & Colucci, W. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117485 · Cited by 196
Intron-exon structure of the human transforming growth factor-β precursor gene
Derynck, R., Rhee, L. M., Chen, E. Y., & Tilburg, A. V. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.7.3188 · Cited by 154
Chimeric and humanized antibodies with specificity for the CD33 antigen
Co, M. S., Avdalovic, N. M., Caron, P. C., Avdalovic, M. V., Scheinberg, D. A., & Queen, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1149 · Cited by 147
Scarabin, P., Bara, L., Ricard, S., Poirier, O., Cambou, J., Arveiler, D., Luc, G., Evans, A. E., Samama, M. M., & Cambien, F. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.886 · Cited by 123
Self-citationGamble, J. R., & Vadas, M. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1149 · Cited by 119
Tiret, L., Ricard, S., Poirier, O., Arveiler, D., Cambou, J., Luc, G., Evans, A., Nicaud, V., & Cambien, F. (1995) · Journal of Hypertension · doi:10.1097/00004872-199503000-00006 · Cited by 99
Self-citationAgrotis, A., Saltis, J., & Bobik, A. (1994) · Hypertension · doi:10.1161/01.hyp.23.5.593 · Cited by 52
Estimation of myriad haplotype frequencies
MacLean, C. J., Morton, N. E., & Rao, D. C. (1985) · Genetic Epidemiology · doi:10.1002/gepi.1370020304 · Cited by 51
TGF-β and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells
Gamble, J. R., Bradley, S., Noack, L., & Vadas, M. A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.949 · Cited by 46
Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium.
Dickson, K. M., Philip, A., Warshawsky, H., O'Connor‐McCourt, M. D., & Bergeron, J. J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117955 · Cited by 40
Cristiani, C., Volpi, D., Landonio, A., & Bertolero, F. (1994) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199406000-00018 · Cited by 21
Cited by
Cytokine gene polymorphism in human disease: on-line databases
Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M., Oksenberg, J., McNicholl, J., Pociot, F., Hardt, C., et al. (1999) · Genes & Immunity · doi:10.1038/sj.gene.6363645 · Cited by 812
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Genetic control of the circulating concentration of transforming growth factor type beta1
Grainger, D. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.93 · Cited by 755
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Awad, M. R., El-Gamel, A., Hasleton, P., Turner, D. M., Sinnott, P. J., & Hutchinson, I. V. (1998) · Transplantation · doi:10.1097/00007890-199810270-00009 · Cited by 638
Metadata
- Authors
- Cambien, F., Ricard, S., Troesch, A., Mallet, C., Générénaz, L., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.-B., & Poirier, O.
- Venue
- Hypertension
- Published
- 1996-11
- Volume
- 28
- Issue
- 5
- Pages
- 881-887
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2031762700
- Cited by
- 363
- References
- 35
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.